Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 3 II, 2001, Pages

  Piedimonte, Giovanni ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CAPSAICIN; CATECHOLAMINE; GLYCOPROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROKININ; NEUROKININ 1 RECEPTOR; NEUROPEPTIDE; NEUROTRANSMITTER; NITRIC OXIDE; PALIVIZUMAB; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

BLOOD VESSEL PERMEABILITY; BRONCHIOLITIS; BRONCHUS REACTIVITY; CONFERENCE PAPER; DISEASE PREDISPOSITION; ENZYME ACTIVITY; IMMUNE RESPONSE; INFLAMMATION; LUNG FUNCTION; NEUROIMMUNOLOGY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VALIDATION PROCESS; WHEEZING;

EID: 0035063637     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.supplement_1.2011113     Document Type: Conference Paper

References (20)

1. Respiratory syncytial virus
2. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
3. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7
4. RSV infection and airway neural control in animal models
5. Immunologic mechanisms in RSV-related allergy and asthma
6. Pulmonary inflammation: A balancing act
7. Neural control mechanisms within airways: Disruption by respiratory syncytial virus
8. Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants
9. Neurogenic amplification of immune complex inflammation
10. Glucocorticoids inhibit neurogenic plasma extravasation and prevent virus-potentiated extravasation in the rat trachea
11. Neutral endopeptidase and kininase II mediate glucocorticoid inhibition of neurogenic inflammation in the rat trachea
12. Virus induces airway hyperresponsiveness to tachykinins: Role of neutral endopeptidase
13. Replication-deficient adenoviral vector for gene transfer potentiates airway neurogenic inflammation
14. Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs
15. Exaggerated neurogenic inflammation and substance P receptor up-regulation in RSV-infected weanling rats
16. Respiratory syncytial virus (RSV) causes long-term potentiation of neurogenic inflammation in rat airways
17. T-lymphocyte subpopulations in bronchial lymphoid tissue of RSV-infected rats overexpress substance P receptors
18. Neuro-immune interactions in a rat model of respiratory syncytial virus infection
19. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
20. A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways